Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation (Q42479815)

1 November 2017

Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation (English)

1 reference

1 November 2017

0 references

1 reference

Spencer J Williams

2

0 references

author name string

Bevyn Jarrott

series ordinal

1

1 reference

1 November 2017

16 July 2015

1 reference

1 November 2017

Neurochemical Research

1 reference

1 November 2017

41

1 reference

1 November 2017

3

1 reference

1 November 2017

523-533

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-015-1661-7

1 November 2017

0 references

cites work

Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Inflammatory cell migration into the central nervous system: a few new twists on an old tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Neuroinflamm-aging and neurodegenerative diseases: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Central nervous system inflammation in disease related conditions: mechanistic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Contributions of vascular inflammation in the brainstem for neurogenic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

The central nervous system and inflammation in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

New perspectives on developing acute stroke therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Neuroprotection and stroke: time for a compromise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Neuroinflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

The free radical hypothesis in idiopathic parkinsonism: evidence against it

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Nonsteroidal anti-inflammatory drugs protect against Parkinson neurodegeneration: can an NSAID a day keep Parkinson disease away?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Structural and microstructral imaging of the brain in alcohol use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Neuroinflammation in the normal aging hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Reactive species mechanisms of cellular hypoxia-reoxygenation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

NXY-059: brain or vessel protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

The COXIB experience: a look in the rearview mirror

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Meloxicam reduces lipopolysaccharide-induced degeneration of dopaminergic neurons in the rat substantia nigra pars compacta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

NRF2-regulation in brain health and disease: implication of cerebral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydrox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Synthesis and evaluation of dithiolethiones as novel cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Hydrogen sulfide-releasing anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Seven decades of angiotensin (1939-2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

The brain renin-angiotensin system: location and physiological roles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Neuroprotective effects of angiotensin receptor blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Purification, molecular cloning, and expression of the mammalian sigma1-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

The sigma-1 receptor: roles in neuronal plasticity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Non-invasive visualization of CNS inflammation with nuclear and optical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Brain inflammation is induced by co-morbidities and risk factors for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Specific imaging of inflammation with the 18 kDa translocator protein ligand DPA-714 in animal models of epilepsy and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1661-7

Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26177578

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26177578

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26177578

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11064-015-1661-7

1 reference

PubMed ID

26177578

Dimensions Publication ID

1 November 2017

0 references

1 reference

PubMed ID

26177578